- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 307/20 - Oxygen atoms
Patent holdings for IPC class C07D 307/20
Total number of patents in this class: 362
10-year publication summary
|
32
|
26
|
18
|
26
|
18
|
17
|
42
|
23
|
17
|
8
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Corsair Pharma, Inc. | 37 |
14 |
| Archer Daniels Midland Company | 1075 |
13 |
| Reata Pharmaceuticals Holdings, LLC | 52 |
9 |
| Zevra Therapeutics, Inc. | 99 |
9 |
| ChromaDex Inc. | 107 |
8 |
| Alphora Research Inc. | 25 |
7 |
| Boehringer Ingelheim International GmbH | 4493 |
5 |
| Vertex Pharmaceuticals Incorporated | 1582 |
5 |
| Daicel Corporation | 2523 |
5 |
| Gilead Sciences, Inc. | 2222 |
5 |
| University of Kansas | 919 |
5 |
| Bristol-myers Squibb Company | 4742 |
4 |
| Syngenta Participations AG | 1524 |
4 |
| Centre National de La Recherche Scientifique | 11023 |
4 |
| Shin-Etsu Chemical Co., Ltd. | 6096 |
4 |
| President and Fellows of Harvard College | 6094 |
4 |
| SK Innovation Co., Ltd. | 1483 |
4 |
| Universite Claude Bernard Lyon 1 | 1077 |
4 |
| Tereos Starch & Sweeteners Belgium | 27 |
4 |
| Eisai R&D Management Co., Ltd. | 1167 |
4 |
| Other owners | 241 |